(Q24246697)

2 July 2019

review article

1 reference

title

Anticholinergic agents for chronic asthma in adults (English)

1 reference

2 July 2019

0 references

1

1 reference

2 July 2019

Peter G Gibson

series ordinal

3

1 reference

2 July 2019

author name string

M Benson

series ordinal

2

1 reference

2 July 2019

publication date

1 January 2004

1 reference

2 July 2019

Cochrane Database of Systematic Reviews

published in

1 reference

2 July 2019

issue

3

1 reference

2 July 2019

page(s)

CD003269

1 reference

2 July 2019

Comparison of the effect of oxitropium bromide and of slow-release theophylline on nocturnal asthma

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Reduction of nocturnal asthma by an inhaled anticholinergic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Synergism between ipratropium and theophylline in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Home nebulizers: can optimal therapy be predicted by laboratory studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

A long-term prospective assessment of home nebulizer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Anticholinergic and sympathomimetic combination therapy of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Effect of four weeks' high dose ipratropium bromide treatment on lung mucociliary clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

The development of subsensitivity to atropine methylnitrate. A double-blind, placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Comparison of inhaled atropine sulphate and atropine methonitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Dose response of ipratropium assessed by two methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Effects of Salbutamol and Isoprenaline Phenylephrine in Reversible Airways Obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Pulmonary function and acid application in the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Protective effect of Duovent versus salbutamol in long-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Bronchodilator Action of the Anticholinergic Drug, Ipratropium Bromide (Sch 1000), as an Aerosol in Chronic Bronchitis and Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

A comparison of ipratropium bromide, deptropine citrate and placebo in asthma and chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Is nocturnal asthma caused by changes in airway cholinergic activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Double-blind study of ipratropium bromide, a new anticholinergic bronchodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Comparative Bronchodilator Responses to Atropine and Terbutaline in Asthma and Chronic Bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Dose-response relationship: fenoterol, ipratropium bromide and their combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Protective effect of drugs on histamine-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Ipratropium bromide in patients with nocturnal asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Relationship between cholinergic airway tone and serum immunoglobulin E in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

A comparison between a combination of ipratropium bromide plus fenoterol in a single metered dose inhaler (Duovent) and salbutamol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Anticholinergic, Antimuscarinic Bronchodilators1,2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

A comparison of three high doses of ipratropium bromide in chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Changes in pulmonary function and cross-sectional area of trachea and bronchi in asthmatics following inhalation of procaterol hydrochloride and ipratropium bromide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Ipratropium bromide and fenoterol by aerosolized solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Dutch CNSLD Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Ipratropium bromide: bronchodilator action and effect on methacholine-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

A single dose comparison of a combination of fenoterol and ipratropium aerosols in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Comparison of ipratropium bromide and fenoterol in asthma and chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Combined Cholinergic Antagonist and β2-Adrenoceptor Agonist Bronchodilator Therapy by Inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Ipratropium bromide: are patients treated with optimal therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

The effect of the circadian rhythm of vagal activity on bronchomotor tone in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

The parasympathetic nervous system and the diurnal variation of lung mechanics in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Double-Blind Crossover Comparison between a <i>β</i>-Adrenergic Agent and a New Anticholinergic Agent by Metered Dose Inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

A comparative study of atropine methonitrate, salbutamol, and their combination in airways obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

The bronchodilator and cardiac effects of five pressure-packed aerosols in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

A comparison of the bronchodilator activity of Sch 1000 and salbutamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Treatment of asthma bronchiale with a combination of ipratropium bromide and fenoterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Twelve-hour bronchodilation in asthma with a single aerosol dose of the anticholinergic compound glycopyrrolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Reproducibility of forced inspiratory and expiratory volumes after bronchodilation in patients with COPD or asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Influence of age on response to ipratropium and salbutamol in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Prolonged effect of inhaled glycopyrrolate in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Failure of Inhaled Corticosteroids to Modify Bronchoconstrictor or Bronchodilator Responsiveness in Middle-Aged Smokers with Mild Airflow Obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Effect of nebulized ipratropium bromide on lung function in nonallergic bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Crossover Study with Nebulized Bronchodilators and Atropine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Effective site of bronchodilation by antiasthma drugs in subjects with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Asthma: Comparative Bronchodilator Effects of Ipratropium Bromide and Isoproterenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Ipratropium does indeed reduce admissions to hospital with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Current therapies for asthma. Promise and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

The use of anticholinergics in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Global initiative for asthma (GINA) and its objectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

21 January 2018

Anticholinergic agents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Ageing, late-onset asthma and the beta-adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Guidelines for the diagnosis and management of asthma: accepting the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Is enough attention being given to the adverse effects of corticosteroid therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Asthma vs. Non-Specific Reversible Airflow Obstruction: Clinical Features and Responsiveness to Anticholinergic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Site of action of ipratropium bromide and clinical and physiological determinants of response in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

The use of beta-agonists and the risk of death and near death from asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Current outpatient management of asthma shows poor compliance with International Consensus Guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Guidelines update: where do the new therapies fit in the management of asthma? NHLBI and WHO Global Initiative for Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003269.PUB2

Whole-body plethysmographic studies on the bronchospasmolytic effect of 2 antiasthmatic drug combinations and ipratropium bromide

21 January 2018

1 reference

12 December 2020

Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients

1 reference

12 December 2020

Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma

1 reference

12 December 2020

Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group

1 reference

12 December 2020

The effect of Tropaacidester Sch 1000 on respiratory resistance (author's transl)

1 reference

12 December 2020

Aerosol Sch 1000. An anticholinergic bronchodilator

1 reference

12 December 2020

Sch 1000: a new anticholinergic bronchodilator

1 reference

12 December 2020

Comparison of the bronchodilating effects of SCH 1000 with isoproterenol in patients with bronchial asthma

1 reference

12 December 2020

The importance of nervus vagus for bronchial obstruction of allergic and non-allergic origin and the therapeutic consequences (author's transl)

1 reference

12 December 2020

Short Communication: Rotation-viscosimetric determinations of the effect of ipratropiumbromide on bronchial excretion/a double blind study

1 reference

12 December 2020

Ipratropium bromide in controlled clinical trials. Short communication (II): Time-response measurements of pulmonary function after ipratropium bromide and isoprenaline

1 reference

12 December 2020

Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma

1 reference

12 December 2020

SOME ADRENERGIC DRUGS AND ATROPINE METHONITRATE GIVEN BY INHALATION FOR ASTHMA: A COMPARATIVE STUDY

1 reference

12 December 2020

SPIROMETRIC INTEGRALS AFTER ISOPRENALINE AND ATROPINE IN ASTHMA

1 reference

12 December 2020

Inhaled beclomethasone improves the course of asthma and COPD.

1 reference

12 December 2020

Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics

1 reference

12 December 2020

Ipratropium bromide (Sch1000) monohydrate aerosol: Bronchodilator effect of three dose levels in asthmatics

1 reference

12 December 2020

Double Blind Comparison of Acute Bronchial and Ventilation-Perfusion Changes to Atrovent and Isoproterenol

1 reference

12 December 2020

Separate and combined effects of corticosteroids and bronchodilators on airflow obstruction and airway hyperresponsiveness in asthma

1 reference

12 December 2020

Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients. Dutch CNSLD Study Group

1 reference

12 December 2020

Effect of age on bronchodilator response

1 reference

12 December 2020

The effect of ipratropium bromide on maximal exercise capacity in asthmatic and non-asthmatic men

1 reference

12 December 2020

Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies

1 reference

12 December 2020

1 reference

12 December 2020

Comparison of ipratropium bromide and salbutamol in a long-term trial in asthmatic and bronchitic patients in a cold climate

1 reference

12 December 2020

A double blind cross-over study of maximal expiratory flows and arterial blood gas tensions in normals, asthmatics and bronchitics after salbutamol and ipratropin

1 reference

12 December 2020

A comparative study of the bronchodilatating effects of ipratropium and terbutalin inhaled with Monaghan IPPB-M 515 by 19 patients with chronic obstructive airways disease

1 reference

12 December 2020

SCH 1000 in psychogenic asthma

1 reference

12 December 2020

Clinical pharmacology of a combination of bronchodilators

1 reference

12 December 2020

Combined inhalation of salbutamol and ipratropin in chronic bronchial obstruction

1 reference

12 December 2020

Treatment of obstructive disease with fenoterol-ipratropiumbromid dosage aerosol (IK 6). Short and long-terms results (author's transl)

1 reference

12 December 2020

Inhaled bronchodilator's in asthma: low or high dose?

1 reference

12 December 2020

Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis

1 reference

12 December 2020

[Randomized and controlled single-case study--a scientific method for individual and difficult therapy decisions in clinical practice exemplified with methotrexate use in asthma]

1 reference

12 December 2020

The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma

1 reference

12 December 2020

Oxitropium bromide: an acute dose response study of a new anticholinergic drug in combination with fenoterol in asthma and chronic bronchitis

1 reference

12 December 2020

Comparison of Berodual and salbutamol in asthma: a multicenter evaluation

1 reference

12 December 2020

A random double-blind trial of the combination of nebulized atropine methylnitrate and albuterol in nocturnal asthma

1 reference

12 December 2020

Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition

1 reference

12 December 2020

Comparison of a combination of fenoterol with ipratropium bromide (Duovent) and salbutamol in young adults with nocturnal asthma

1 reference

12 December 2020

Relative bronchodilatory responsiveness attributable to sympathetic and parasympathetic activity in bronchial asthma

1 reference

12 December 2020

Effect of four-week treatment with oxitropium bromide on lung mucociliary clearance in patients with chronic bronchitis or asthma

1 reference

12 December 2020

The response pattern of patients with chronic airway obstruction to bronchodilators.

1 reference

12 December 2020

Validity of air-helium DVmax measurements in trials of bronchodilators

1 reference

12 December 2020

[Berodual in the treatment of bronchial asthma]

1 reference

12 December 2020

Determining optimal therapy--randomized trials in individual patients

1 reference

12 December 2020

A comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solutions assessing dose-response and duration of action.

1 reference

12 December 2020

Single dose comparison of salbutamol and a fenoterol/ipratropium combination from metered aerosols in patients with asthma.

1 reference

12 December 2020

Use of ipratropium bromide in asthma. Results of a multi-clinic study

1 reference

12 December 2020

Bronchoconstriction induced by nebulised ipratropium bromide: relation to the bromide ion

1 reference

12 December 2020

The combination of fenoterol and ipratropium bromide in bronchial asthma: comparison of the acute effects of two different dosages

1 reference

12 December 2020

Efficacy and compliance to prolonged Duovent treatment of bronchospasm. Comparison with salbutamol

1 reference

12 December 2020

Comparison of the bronchodilatation of ipratropium bromide and fenoterol nebuliser solutions administered alone and in combination

1 reference

12 December 2020

Single-dose comparison of salbutamol and Duovent-Berodual in asthma

1 reference

12 December 2020

Comparison of fenoterol, ipratropium bromide, and their combination in patients with asthma or chronic airflow obstruction

1 reference

12 December 2020

Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose-response and duration of action

1 reference

12 December 2020

Blind randomized cross-over comparative study of salbutamol and the combination fenoterol-ipratropium IK6 in patients with bronchial asthma

1 reference

12 December 2020

Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution

1 reference

12 December 2020

A dose response study comparing Duovent vs salbutamol

1 reference

12 December 2020

Acute effects of fenoterol (Berotec) and ipratropium bromide (Atrovent) alone and in combination on bronchial hyperresponsiveness in asthmatic subjects

1 reference

12 December 2020

1 reference

12 December 2020

The duration of action of the combination of fenoterol hydrobromide and ipratropium bromide in protecting against asthma provoked by hyperpnea

1 reference

12 December 2020

Cumulative dose-response curves for assessing combined effects of salbutamol and ipratropium bromide in chronic asthma

1 reference

12 December 2020

Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Comparison with a beta-adrenergic agent

1 reference

12 December 2020

Parasympathetic nervous system in nocturnal asthma

1 reference

12 December 2020

[The role of anticholinergic drugs in the treatment of bronchospastic conditions]

1 reference

12 December 2020

Use of ipratropium aerosol in the long-term management of asthma

1 reference

12 December 2020

Oral atropine in the treatment of chronic asthma

1 reference

12 December 2020

Comparative study of anticholinergic and betamimetic agents in the treatment of asthma attacks

1 reference

12 December 2020

Combination of oxitropium bromide and salbutamol in the treatment of asthma with pressurized aerosols

1 reference

12 December 2020

The value of atropine in the documentation of reversible airways obstruction

1 reference

12 December 2020

Prolongation of gastric emptying by aerosolized atropine

1 reference

12 December 2020

Oxitropium, salbutamol and their combination in asthma

1 reference

12 December 2020

[Can the association of an atropinic (SCH 1000) and a sympathicomimetic improve the bronchodilatation obtained by a sympathicomimetic alone (author's transl)]

1 reference

12 December 2020

[Comparative study of the bronchodilating effect of SCH 1000, berotec and of the association of the two drugs in patients with spastic bronchitis (author's transl)]

1 reference

12 December 2020

Oxitropium bromide (Ba 253), an advance in the field of anticholinergic bronchodilating treatments. Preliminary results

1 reference

12 December 2020

Inhaled atropine in asthma

1 reference

12 December 2020

[Atropine derivatives as dose aerosol in inhalation therapy of bronchial asthma]

1 reference

12 December 2020

[Double-blind study for the comparison of the broncholytic effect of a new tropic acid derivative with isoprenaline]

1 reference

12 December 2020

Lung function studies with the bronchodilator terbutaline

1 reference

12 December 2020

The effect of bronchodilator aerosols on the peak expiratory flow rate in asthmatic patients

1 reference

12 December 2020

Atropine methonitrate in bronchial asthma

1 reference

12 December 2020

The short-term bronchodilator effects of fenoterol and ipratropium in asthma

1 reference

12 December 2020

Use of Ipratropium Bromide in Patients with Severe Airways Obstruction

1 reference

12 December 2020

The addition of an aerosol anticholinergic to an oral beta agonist plus theophylline in asthma and bronchitis. A double-blind single dose study

1 reference

12 December 2020

A therapeutic comparison of ipratropium bromide and salbutamol in asthmatic patients

1 reference

12 December 2020

A Comparative Study of Various Combinations of Ipratropium Bromide and Metaproterenol in Allergic Asthmatic Patients

1 reference

12 December 2020

Combination of fenoterol and ipratropium bromide in the treatment of bronchial asthma

1 reference

12 December 2020

Salbutamol versus Duovent (a combination of fenoterol and ipratropium bromide) in asthma

1 reference

12 December 2020

Acute effect of ipratropium bromide at therapeutic dose on mucus transport of adult asthmatics

1 reference

12 December 2020

Anticholinergic drugs in airways obstruction

1 reference

12 December 2020

Effect of the inhalation of an atropine derivative (ipratropium bromide) in powder form on respiratory mechanics in obstructive airway diseases

1 reference

12 December 2020

Comparison by double-blind study of the combination of an aerosol of salbutamol and ipratropium bromide and its individual effect in chronic bronchitis and bronchial asthma

1 reference

12 December 2020

Combined therapy with ipratropium and theophylline in asthma

1 reference

12 December 2020

A comparison of oxitropium bromide and ipratropium bromide in asthma

1 reference

12 December 2020

A comparison of effects of inhaling a combined preparation of fenoterol with ipratropium bromide (Duovent) with those of fenoterol and salbutamol

1 reference

12 December 2020

Comparison of Duovent and salbutamol inhalers in chronic stable asthma

1 reference

12 December 2020

Response to Duovent of chronic reversible airways obstruction--a controlled trial in general practice

1 reference

12 December 2020

Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity

1 reference

12 December 2020

Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol

1 reference

12 December 2020

Comparison of the effects of inhalation of a single dose of a ipratropium bromide-fenoterol combination with a single dose of fenoterol

1 reference

12 December 2020

Effects of administration of a single dose of iprafen (l puff) compared with those of a single dose of ipratropium bromide (40 mcg.) and of fenoterol (100 mcg.)

1 reference

12 December 2020

1 reference

12 December 2020

A cumulative dose response study of oxitropium bromide (Ba 253) in asthmatics

1 reference

12 December 2020

Bronchodilator characteristics of nebulized metaproterenol sulfate, isoetharine, and atropine in chronic asthma

1 reference

12 December 2020

Treatment of adult asthma: Controlled double-blind clinical trial of oxitropium bromide

1 reference

12 December 2020

[Comparative effects of terbutaline sulphate and ipratropium bromide on the respiratory system (author's transl)]

1 reference

12 December 2020

Comparison of atropine with ipratropium bromide in patients with reversible airways obstruction unresponsive to salbutamol

1 reference

12 December 2020

The effect of vagolytic drugs on airway obstruction in patients with bronchial asthma

1 reference

12 December 2020

Combination bronchodilator therapy in asthma

1 reference

12 December 2020

Comparison of ipratropium bromide and salbutamol by aerosolized solution

1 reference

12 December 2020

Anticholinergic versus beta 2-adrenergic therapy in allergic airways obstruction: double-blind trials on bronchodilator effect and antiallergic protection of oxitropium bromide and fenoterol

1 reference

12 December 2020

Atropine responsiveness in asthma in relation to steroid aerosol therapy

1 reference

12 December 2020

Density dependence of expiratory flow and bronchodilator response in asthma

1 reference

12 December 2020

The bronchodilator action of theophylline aerosol in subjects with chronic airflow obstruction

1 reference

12 December 2020

Continuous and on demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: four-year follow-up randomized controlled study

1 reference

12 December 2020

Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease.

1 reference

12 December 2020

Importance of total serum IgE for improvement in airways hyperresponsiveness with inhaled corticosteroids in asthma and chronic obstructive pulmonary disease. The Dutch CNSLD Study Group

1 reference

12 December 2020

[Effect of fenoterol, ipratropium bromide and combination drug-berodual-on selected clinical parameters and lung function in patients with asthma]

1 reference

12 December 2020

Comparison of a single dose of aerosol salbutamol and fenoterol/ipratropium on bronchial asthmatic patients

1 reference

12 December 2020

A new parasympatholytic bronchodilator: a study of its onset of effect after inhalation

1 reference

12 December 2020

Quality-of-life in a long-term multicentre trial in chronic nonspecific lung disease: assessment at baseline. The Dutch CNSLD Study Group.

1 reference

12 December 2020

Effects of aerosol ipratropium bromide on cardiac vagal tone

1 reference

12 December 2020

Guidelines on the management of asthma. Statement by the British Thoracic Society, the Brit. Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal Colle

1 reference

12 December 2020

Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long-term inhaled corticosteroid treatment. Dutch CNSLD Study Group

1 reference

12 December 2020

The Asthma Symptom Profile: a psychophysically based scale for assessment of asthma symptoms

1 reference

12 December 2020

Terbutaline controlled-release tablets and ipratropium aerosol in nocturnal asthma

1 reference

12 December 2020

Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma

1 reference

12 December 2020

Pathophysiology of asthma

1 reference

12 December 2020

The effects of the combination of inhaled ipratropium and oral theophylline in asthma

1 reference

12 December 2020

Salmeterol compared with current therapies in chronic asthma

1 reference

12 December 2020

10.1002/14651858.CD003269.PUB2

Identifiers

DOI

1 reference

2 July 2019

OpenCitations bibliographic resource ID

1971661

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

2 July 2019

PubMed ID

15266477

1 reference

2 July 2019